Published in Br Med J on August 04, 1973
Pathogenesis and treatment of acute intermittent porphyria: discussion paper. J R Soc Med (1983) 0.90
Catecholamine uptake, accumulation, and release in acute porphyria. J Clin Invest (1977) 0.84
Treatment of acute intermittant porphyria. Br Med J (1973) 0.75
Propranolol in acute intermittent porphyria. Postgrad Med J (1979) 0.75
The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem (1956) 16.55
The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem (1966) 5.70
A simple analysis for normetanephrine and metanephrine in urine. Clin Chim Acta (1960) 3.69
The neuropathology of acute porphyria. J Pathol Bacteriol (1956) 2.50
Delta-aminolevulinic acid synthetase. I. Studies in liver homogenates. J Biol Chem (1966) 2.45
Acute intermittent porphyria: a study of 50 cases. Q J Med (1959) 1.90
Depression of delta-aminolaevulic acid dehydrase activity by ethanol in man and rat. Clin Sci (1971) 1.45
Delta-aminolaevulinic acid synthetase activity in normal and porphyric human livers. S Afr Med J (1967) 1.39
[Hypertension and tachycardia in acute intermittent porphyria]. Klin Wochenschr (1970) 1.15
The effects of certain barbiturates on the hepatic porphyrin metabolism of rats. Biochem Pharmacol (1970) 0.86
Inactivation of poliovirus in digested sludge. Appl Environ Microbiol (1976) 6.23
A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br (2003) 4.16
Identification of the virucidal agent in wastewater sludge. Appl Environ Microbiol (1977) 3.42
Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst (2001) 3.02
Blood-lead and hypertension. Lancet (1976) 2.82
Inactivation of enteric viruses in wastewater sludge through dewatering by evaporation. Appl Environ Microbiol (1977) 2.70
Heat inactivation of poliovirus in wastewater sludge. Appl Environ Microbiol (1976) 2.59
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant (2012) 2.46
Effect of cytosine arabinoside on viral-specific protein synthesis in cells infected with herpes simplex virus. J Virol (1975) 2.40
Environmental lead pollution in an urban soft-water area. Br Med J (1972) 2.28
The diagnosis of industrial lead poisoning. Br J Ind Med (1968) 2.23
Do pregnant women take their iron? Lancet (1969) 2.10
Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc Natl Acad Sci U S A (1997) 2.08
Lead poisoning in rural Scotland. Br Med J (1972) 2.08
Efficiency of human rotavirus propagation in cell culture. J Clin Microbiol (1984) 2.07
Summaries and selective destruction as a solution to the hospital record storage problem. Lancet (1967) 2.05
Choleic acids. Biochem J (1932) 2.02
Positive spillover effects of prescribing requirements: increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer. Intern Med J (2012) 2.02
Lead and delta-aminolaevulinic acid dehydratase levels in mentally retarded children and in lead-poisoned suckling rats. Lancet (1970) 1.93
35Cl NMR studies of zinc adenosine diphosphate complexes. Biochem Biophys Res Commun (1967) 1.92
Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood. Q J Med (1977) 1.91
Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther (2012) 1.89
Diagnosis of upper gastro-intestinal bleeding. Br Med J (1965) 1.84
Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes. Am J Transplant (2013) 1.77
Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria. Gastroenterology (1993) 1.76
Controlled trial of haem arginate in acute hepatic porphyria. Lancet (1989) 1.75
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
Low level exposure to lead. BMJ (1990) 1.67
K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction. J Gastroenterol Hepatol (2000) 1.64
Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence. J Virol (1993) 1.64
Mechanism of poliovirus inactivation by ammonia. J Virol (1978) 1.64
Colorectal cancer: a model for epigenetic tumorigenesis. Gut (2006) 1.62
Skin test results and self-reported symptom severity in allergic rhinitis: The role of psychological factors. Clin Exp Allergy (2006) 1.59
The drug disc. Warning system for drug interactions. Lancet (1973) 1.56
Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology (1995) 1.56
An assessment of digoxin radio-immunoassay. Scott Med J (1973) 1.55
Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particle. Trends Biochem Sci (1998) 1.55
Debilitating beliefs, emotional distress and quality of life in patients given immunotherapy for insect sting allergy. Clin Exp Allergy (1999) 1.52
Nature of the scrapie agent: evidence against a viroid. J Virol (1974) 1.48
Life satisfaction and quality in Korean War veterans five decades after the war. J Epidemiol Community Health (2009) 1.48
Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol (2009) 1.47
Magnesium binding by Escherichia coli ribosomes. J Mol Biol (1966) 1.46
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. Neurology (1996) 1.45
Depression of delta-aminolaevulic acid dehydrase activity by ethanol in man and rat. Clin Sci (1971) 1.45
Molecular characterization of serotype G9 rotavirus strains from a global collection. Virology (2000) 1.43
Re-assessment of risk factors for sporadic Salmonella serotype Enteritidis infections: a case-control study in five FoodNet Sites, 2002-2003. Epidemiol Infect (2006) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension. Am J Cardiol (2001) 1.41
Blood lead levels in normal and mentally deficiency children. Arch Dis Child (1967) 1.41
A database on dyspepsia. Gut (1994) 1.41
Ascorbic-acid levels in leucocytes of patients with gastrointestinal haemorrhage. Lancet (1968) 1.40
Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses. Arch Virol (1996) 1.40
Writing case histories. Int J Psychoanal (1997) 1.39
Role of chronic low-level lead exposure in the aetiology of mental retardation. Lancet (1975) 1.39
Medics in the Israel Defense Forces and their experience in trauma care during peacetime. Isr Med Assoc J (1999) 1.38
Between empathy and judgment. J Am Psychoanal Assoc (1999) 1.38
Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. Acta Paediatr (1999) 1.38
Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol (1993) 1.36
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Methods (1991) 1.35
Enteric virus and indicator bacteria levels in a water treatment system modified to reduce trihalomethane production. Appl Environ Microbiol (1984) 1.35
Effects of moisture content on long-term survival and regrowth of bacteria in wastewater sludge. Appl Environ Microbiol (1981) 1.35
Hydrogen production by Anabaena cylindrica: effects of varying ammonium and ferric ions, pH, and light. Appl Environ Microbiol (1978) 1.33
Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology (1994) 1.33
Identification of detergents as components of wastewater sludge that modify the thermal stability of reovirus and enteroviruses. Appl Environ Microbiol (1978) 1.33
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization. Clin Chem (2000) 1.32
Renal insufficiency associated with excessive lead exposure. Br Med J (1977) 1.29
Treatment with haematin in acute hepatic porphyria. Q J Med (1981) 1.29
Strength training increases resting metabolic rate and norepinephrine levels in healthy 50- to 65-yr-old men. J Appl Physiol (1985) (1994) 1.29
Mechanism of inactivation of enteric viruses in fresh water. Appl Environ Microbiol (1986) 1.27
Circulatory and metabolic effects of oxygen in myocardial infarction. Br Med J (1968) 1.26
Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol (1992) 1.25
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol Sci (1999) 1.23
Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles. J Virol (1999) 1.22
The neurotoxicology of lead. Neurotoxicology (1986) 1.22
Lead poisoning as a disorder of heme synthesis. Semin Hematol (1968) 1.22
Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis. Am J Ophthalmol (1984) 1.21
Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins. J Virol (1990) 1.20
Ascorbic acid deficiency in liver disease. Gut (1976) 1.20
Computer-assisted interactive three-dimensional planning for neurosurgical procedures. Neurosurgery (1996) 1.19
pH modification of the effects of detergents on the stability of enteric viruses. Appl Environ Microbiol (1979) 1.19
Drinking water as a source of lead pollution. Environ Health Perspect (1974) 1.19
Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue. Br J Clin Pharmacol (1980) 1.19